---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-012858"
form_type: "8-K/A"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2024-04-02T23:59:59+00:00"
generated_at: "2026-06-04T03:26:22.055053+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience enters equity line with Triton Funds for up to $850k, issues warrants at $2.00

## Summary
- Purchase Agreement to sell up to 1M shares at $0.85/share, gross proceeds up to $850k, expires Dec 31, 2024.
- Private placement warrants to buy 1M shares at $2.00/share, exercisable for 5 years from issuance.
- Stockholder approval may be required if issuances exceed 523,344 shares (19.9% of outstanding) under Nasdaq rules.
- Warrants are unregistered; cashless exercise permitted if no effective registration statement.
- Triton's beneficial ownership limited to 9.99% of outstanding common stock.

## SEC filing metadata
- accession: 0001493152-24-012858
- form_type: 8-K/A
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2024-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315224012858/0001493152-24-012858-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315224012858/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-012858
- JSON: https://secwatch.observer/filing/0001493152-24-012858.json
- Plain text: https://secwatch.observer/filing/0001493152-24-012858.txt

## Key facts
- Material Agreements
  INVO Fertility, Inc. entered into Purchase Agreement with Triton Funds LP valued at up to $850,000 (effective 2024-03-27).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Triton Funds LP
  - Value: up to $850,000
  - Effective: 2024-03-27
  source text: On March 27, 2024, INVO Bioscience, Inc., a Nevada corporation (the “ Company ”) entered into a purchase agreement (the “ Purchase Agreement ”) with Triton Funds LP (“ Triton ”), pursuant to which the Company agreed to sell, and Triton agreed to purchase, upon the Company’s request in one or more transactions, up to 1,000,000 shares of the Company’s common stock, par value $0.0001 per share, providing aggregate gross proceeds to the Company of up to $850,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315224012858/0001493152-24-012858-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.